Steve Kelly and the other panelists discuss their paper titled “Assessing the policy and access environment across European countries for SMA patients.”
For more information on this event, click here.
Potential impact of the MFN model on innovative medicine
While the content of the deals are not public, the White House has announced that each agreement includes language that manufacturers guarantee MFN pricing for...